EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions

Kai-Yun Chen iD, Xu-Huan Li, Dan Chen, Shi-da Qian, Run-Hong Mei, Qian Li, Xue-Feng Yu, Xi-Jing He

PLOS One · 2025

DOI: 10.1371/journal.pone.0325190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Kai-Yun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. Hauptthemen laut MEDLINE: Apoptosis, Femur Head Necrosis, PPAR gamma, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Steroid-induced osteonecrosis of the femoral head (SONFH) is a serious bone disease commonly seen in patients on long-term glucocorticoid therapy. Although statins have shown some efficacy in improving lipid metabolism, their efficacy in the treatment of SONFH remains limited. PPARγ inhibitors may enhance the efficacy of statins through several mechanisms. This study aims to investigate how PPARγ inhibitors may enhance the effects of statins in the treatment of SONFH by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions.

Methods

We first treated osteoblasts in vitro with high concentrations of hormones to simulate the SONFH environment. We then treated the cells with either the PPARγ inhibitor GW9662, the statin lovastatin, or a combination of both. We assessed cell proliferation and apoptosis using CCK-8, flow cytometry and Western blotting. We then established a SONFH rabbit model using high doses of methylprednisolone and lipopolysaccharide. The rabbits were randomly divided into four groups: control group, lovastatin group, GW9662 group and combination therapy group. We observed hip joint MRI before treatment, after 4 weeks of treatment, and 4 weeks after stopping treatment. We performed hematoxylin-eosin staining of the femoral head and analysed serum lipoprotein subfractions using VAP technology. In addition, we used quantitative polymerase chain reaction (qPCR) to analyse the expression of genes related to lipid metabolism at week 3.

Results

In vitro experiments showed that both GW9662 and lovastatin effectively inhibited hormone-induced apoptosis. In the animal studies, imaging and pathological results showed that the progression of SONFH was slower in the combination therapy group than in the other groups. VAP analysis showed that the lovastatin group had disturbed lipoprotein subfractions at the fourth week after stopping treatment, while the combination therapy group had more stable lipoprotein subfractions.

Conclusion

PPARγ inhibitors significantly enhance the efficacy of statins in the treatment of SONFH by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions. These findings provide new insights into the clinical management of SONFH and suggest that combination therapy may be an effective strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisFemur Head NecrosisPPAR gammaHydroxymethylglutaryl-CoA Reductase InhibitorsAnilidesLipoproteinsLovastatinAnimalsRabbitsOsteoblastsCell ProliferationMaleDisease Models, AnimalMethylprednisoloneFemur HeadSteroids

Substanzen

PPAR gammaHydroxymethylglutaryl-CoA Reductase Inhibitors2-chloro-5-nitrobenzanilideAnilidesLipoproteinsLovastatinMethylprednisoloneSteroids

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
  • Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • First Affiliated Hospital of Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Jiangxi Provincial Key Laboratory of Oral Diseases, Department of Stomatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Orthopedic Hospital, Xi'an International Medical Center Hospital, Xi'an, Shaanxi Province, China.

ORCID-Profile: Kai-Yun Chen

Zitieren

APA

Chen, K. Y., Li, X. H., Chen, D., Qian, S. D., Mei, R. H., Li, Q., Yu, X. F., & He, X. J. (2025). PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions. PLOS One. https://doi.org/10.1371/journal.pone.0325190

Vancouver

Chen KY, Li XH, Chen D, Qian SD, Mei RH, Li Q, et al. PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions. PLOS One. 2025. doi:10.1371/journal.pone.0325190

BibTeX
@article{Chen2025,
  author = {Chen, Kai-Yun and Li, Xu-Huan and Chen, Dan and Qian, Shi-da and Mei, Run-Hong and Li, Qian and Yu, Xue-Feng and He, Xi-Jing},
  title = {PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325190}
}
Kostenlos starten →